Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Among adults using PAP therapy, Zepbound led to 29 fewer breathing disruptions per hour compared to six with placebo
It has been known for years that weight loss may improve fertility by allowing women to ovulate
Phase 2 trials showed average weight loss of 24% at the highest dose over 48 weeks Significant improvements in blood glucose control and insulin sensitivity were observed Similar medications have shown PCOS-specific benefits including improved menstrual regularity Gastrointestinal side effects were most common but typically improved with continued use Specific PCOS trials are ongoing and will provide direct evidence for this population Comparing Retatrutide to Current PCOS Treatments Understanding how retatrutide fits into the current landscape of PCOS treatments helps frame its potential role in future management approaches
Diabetes Care (2016) 39(11):197280
